Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China · Delayed Price · Currency is CNY 8.72
+0.06 (0.69%)
At close: Jul 31, 2026
SHE:301301 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 664.17 | 734.21 | 1,088 | 760.94 | 1,632 | 510.05 |
Trading Asset Securities | - | - | - | - | 1.15 | 1.21 |
Cash & Short-Term Investments | 664.17 | 734.21 | 1,088 | 760.94 | 1,633 | 511.26 |
Cash Growth | -41.89% | -32.54% | 43.03% | -53.41% | 219.44% | 0.13% |
Accounts Receivable | 2,011 | 1,785 | 1,572 | 1,403 | 1,417 | 1,178 |
Other Receivables | 0.91 | 0.28 | 0.53 | 0.63 | 2.59 | 1.19 |
Receivables | 2,012 | 1,785 | 1,573 | 1,404 | 1,420 | 1,179 |
Inventory | 1,322 | 1,500 | 1,342 | 1,676 | 1,384 | 1,453 |
Other Current Assets | 192.81 | 189.69 | 141.02 | 114.94 | 91.25 | 72.12 |
Total Current Assets | 4,191 | 4,209 | 4,144 | 3,956 | 4,528 | 3,216 |
Property, Plant & Equipment | 5,668 | 5,731 | 6,046 | 5,870 | 5,539 | 5,920 |
Long-Term Investments | 252.93 | 202.2 | 70.69 | 6.78 | 6.93 | - |
Goodwill | 1.37 | 1.37 | 1.37 | 1.37 | 1.37 | 1.37 |
Other Intangible Assets | 236.68 | 228.91 | 235.83 | 257.99 | 283.07 | 271.83 |
Long-Term Deferred Tax Assets | 20.17 | 21.77 | 20.9 | 21.65 | 11.34 | 6.96 |
Long-Term Deferred Charges | 0.44 | 0.66 | 1.54 | 2.42 | 3.4 | 4.72 |
Other Long-Term Assets | 32.05 | 34.66 | 33.25 | 21.64 | 17.97 | 40.94 |
Total Assets | 10,403 | 10,429 | 10,554 | 10,139 | 10,390 | 9,462 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 695.59 | 262.62 | 383.33 | 479.98 | 282.99 | 427.66 |
Accrued Expenses | 27.59 | 40.36 | 64.32 | 31.57 | 66.32 | 20.7 |
Short-Term Debt | 760.48 | 560.35 | 210.15 | 850.68 | 978.83 | 700.35 |
Current Portion of Long-Term Debt | 10.56 | 146.11 | 608.16 | 538.36 | 847.26 | 878.17 |
Current Portion of Leases | - | 10.46 | 8.9 | 3.8 | 1.88 | 1.02 |
Current Income Taxes Payable | 89.92 | 33.88 | 66.37 | 36.52 | 24.79 | 0.14 |
Current Unearned Revenue | 15.27 | 19.23 | 66.82 | 28.94 | 38 | 21.26 |
Other Current Liabilities | 31.69 | 671.36 | 539.49 | 565.85 | 467.33 | 513.58 |
Total Current Liabilities | 1,631 | 1,744 | 1,948 | 2,536 | 2,707 | 2,563 |
Long-Term Debt | - | - | 146 | 357.33 | 1,428 | 2,092 |
Long-Term Leases | 448.06 | 469.73 | 451.12 | 188.12 | 10.2 | 3.13 |
Long-Term Unearned Revenue | 100.06 | 103.8 | 92.51 | 83.74 | 34.24 | 26.22 |
Long-Term Deferred Tax Liabilities | - | - | - | 0.31 | 0.08 | - |
Other Long-Term Liabilities | 5.27 | 3.74 | - | 0.08 | - | - |
Total Liabilities | 2,184 | 2,322 | 2,637 | 3,165 | 4,180 | 4,684 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 2,230 | 2,230 | 2,227 | 2,223 | 2,223 | 2,000 |
Additional Paid-In Capital | 3,299 | 3,298 | 3,284 | 3,252 | 3,229 | 2,431 |
Retained Earnings | 2,665 | 2,554 | 2,386 | 1,486 | 752.21 | 340.7 |
Comprehensive Income & Other | 0.19 | 0.19 | -0.1 | - | - | - |
Total Common Equity | 8,194 | 8,082 | 7,898 | 6,960 | 6,204 | 4,771 |
Minority Interest | 24.66 | 25.37 | 18.83 | 12.87 | 6 | 6 |
Shareholders' Equity | 8,218 | 8,108 | 7,916 | 6,973 | 6,210 | 4,777 |
Total Liabilities & Equity | 10,403 | 10,429 | 10,554 | 10,139 | 10,390 | 9,462 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 1,219 | 1,187 | 1,424 | 1,938 | 3,266 | 3,675 |
Net Cash (Debt) | -554.94 | -452.44 | -336 | -1,177 | -1,633 | -3,163 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.25 | -0.20 | -0.15 | -0.53 | -0.83 | -1.70 |
Filing Date Shares Outstanding | 2,230 | 2,230 | 2,227 | 2,223 | 2,223 | 2,000 |
Total Common Shares Outstanding | 2,230 | 2,230 | 2,227 | 2,223 | 2,223 | 2,000 |
Working Capital | 2,560 | 2,465 | 2,197 | 1,421 | 1,820 | 653.24 |
Book Value Per Share | 3.67 | 3.62 | 3.55 | 3.13 | 2.79 | 2.39 |
Tangible Book Value | 7,956 | 7,852 | 7,660 | 6,701 | 5,920 | 4,498 |
Tangible Book Value Per Share | 3.57 | 3.52 | 3.44 | 3.01 | 2.66 | 2.25 |
Buildings | - | 3,186 | 3,060 | 2,779 | 2,637 | 2,560 |
Machinery | - | 6,346 | 6,226 | 5,861 | 5,815 | 5,725 |
Construction In Progress | - | 277.21 | 285.31 | 537.8 | 60.12 | 96.38 |